• Home
  • Chemical probing of HER2-amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinib.

Chemical probing of HER2-amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinib.

Author List
Amin DN, Ruiz-Saenz A, Gulizia N, Moasser MM
Publication
Oncotarget
Publication ID (Profile URL)
https://researcherprofiles.org/profile/1195569
Publication Year
2015
PubMed ID
26516700
Publication Title
Amin DN, Ruiz-Saenz A, Gulizia N, Moasser MM. Chemical probing of HER2-amplified cancer cells identifies TORC2 as a particularly effective secondary target for combination with lapatinib. Oncotarget. 2015 Dec 01; 6(38):41123-33.